X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE IPCA LABS SUVEN LIFE/
IPCA LABS
 
P/E (TTM) x 16.5 28.0 59.1% View Chart
P/BV x 3.1 2.1 143.1% View Chart
Dividend Yield % 1.2 0.2 509.5%  

Financials

 SUVEN LIFE   IPCA LABS
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
IPCA LABS
Mar-17
SUVEN LIFE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs339643 52.6%   
Low Rs144503 28.7%   
Sales per share (Unadj.) Rs39.2254.4 15.4%  
Earnings per share (Unadj.) Rs7.516.1 46.4%  
Cash flow per share (Unadj.) Rs8.829.8 29.5%  
Dividends per share (Unadj.) Rs2.001.00 200.0%  
Dividend yield (eoy) %0.80.2 474.5%  
Book value per share (Unadj.) Rs49.0194.6 25.2%  
Shares outstanding (eoy) m127.28126.20 100.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.22.3 273.2%   
Avg P/E ratio x32.435.7 90.8%  
P/CF ratio (eoy) x27.519.2 143.0%  
Price / Book Value ratio x4.92.9 167.3%  
Dividend payout %26.86.2 430.7%   
Avg Mkt Cap Rs m30,73272,300 42.5%   
No. of employees `0001.013.3 7.2%   
Total wages/salary Rs m4166,960 6.0%   
Avg. sales/employee Rs Th5,236.12,413.5 217.0%   
Avg. wages/employee Rs Th436.5523.2 83.4%   
Avg. net profit/employee Rs Th995.5152.4 653.0%   
INCOME DATA
Net Sales Rs m4,99532,106 15.6%  
Other income Rs m194226 85.7%   
Total revenues Rs m5,18932,332 16.0%   
Gross profit Rs m1,2334,448 27.7%  
Depreciation Rs m1671,730 9.7%   
Interest Rs m54241 22.5%   
Profit before tax Rs m1,2052,703 44.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255675 37.8%   
Profit after tax Rs m9502,028 46.8%  
Gross profit margin %24.713.9 178.1%  
Effective tax rate %21.225.0 84.7%   
Net profit margin %19.06.3 301.0%  
BALANCE SHEET DATA
Current assets Rs m4,98617,340 28.8%   
Current liabilities Rs m1,0429,559 10.9%   
Net working cap to sales %79.024.2 325.8%  
Current ratio x4.81.8 263.7%  
Inventory Days Days61100 60.8%  
Debtors Days Days3957 68.8%  
Net fixed assets Rs m3,12620,779 15.0%   
Share capital Rs m127252 50.4%   
"Free" reserves Rs m3,71724,499 15.2%   
Net worth Rs m6,23624,553 25.4%   
Long term debt Rs m4323,517 12.3%   
Total assets Rs m8,07939,595 20.4%  
Interest coverage x23.212.2 190.0%   
Debt to equity ratio x0.10.1 48.4%  
Sales to assets ratio x0.60.8 76.2%   
Return on assets %12.45.7 216.9%  
Return on equity %15.28.3 184.4%  
Return on capital %18.910.5 180.0%  
Exports to sales %87.548.6 179.9%   
Imports to sales %12.214.2 85.9%   
Exports (fob) Rs m4,37115,617 28.0%   
Imports (cif) Rs m6114,571 13.4%   
Fx inflow Rs m4,66615,617 29.9%   
Fx outflow Rs m9425,828 16.2%   
Net fx Rs m3,7249,790 38.0%   
CASH FLOW
From Operations Rs m9222,764 33.4%  
From Investments Rs m-619-1,432 43.3%  
From Financial Activity Rs m-698-1,591 43.9%  
Net Cashflow Rs m-396-259 152.9%  

Share Holding

Indian Promoters % 63.4 45.9 138.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 0.0 25.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.4 209.8%  
Shareholders   37,287 36,892 101.1%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 17, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - BIOCON LTD COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS